The Virus Counter 3100 comparison should start from one essential point: the Virus Counter addresses a specific need, namely direct viral particle counting within minutes, whereas an infectivity assay may require several days. Its value mainly relies on fluorescent labeling, which provides important biological specificity in certain matrices.
However, this specificity comes with operational costs. Reagents, consumables, sample preparation, incubation, controls and fluidic maintenance must be considered before comparing this technology with a label-free counting solution. The choice therefore depends not only on speed, but also on sample type, concentration, particle size and the expected level of information.
Understanding the Virus Counter principle
The Virus Counter is based on a fluorescence counting method. Before measurement, viral samples are labeled with fluorescent dyes or fluorescent antibody reagents. Once prepared, the sample is guided through a fluidic stream and hydrodynamically focused in front of a laser.
Detection is then based on the light emitted by the fluorophores. Combined with the measured flow rate, this information provides a total particle concentration. The interest of this approach lies in its ability to count particles that match a given biological signature.
The Combo Dye reagent combines two fluorogenic dyes targeting the viral genome and envelope protein. Only simultaneous events on both channels are counted as intact particles. ViroTag reagents are based on antibodies directed against defined viral epitopes.
This labeling logic makes it possible to distinguish a viral particle from other particles present in a complex matrix.
What fluorescence specificity provides
Fluorescence delivers information that a purely scattering-based method cannot provide. A particle is not counted only because it has a size compatible with the target population. It is counted because it carries a signal linked to a targeted biological element.
This difference matters when samples contain debris, vesicles, non-viral particles or a crude matrix that is difficult to interpret. Under these conditions, label-free counting can detect particles, but it cannot always determine whether they actually correspond to the virus being studied.
A fluorescent reagent-based method can therefore be relevant for samples requiring more specific identification. It answers a different question from simple counting: the aim is not only to know how many particles are present, but to know whether those particles correspond to the viral target.
Constraints associated with reagents
The specificity of the Virus Counter comes with several constraints. Each measurement requires consumables: reagent kits, sheath fluid, wash fluid, dilution buffers and items required for sample preparation.
These reagents have a limited shelf life and may require cold storage. They are consumed by samples, but also by blanks, controls and runs that do not necessarily produce usable data. The real cost is therefore not limited to the price of a kit divided by a theoretical number of tests.
Preparation also adds a labeling step before analysis. Operator time, dilutions, incubation and fluidic circuit maintenance must all be considered. These factors become important when the laboratory performs many runs or works with several types of viruses.
Another point concerns reagent coverage. Antibodies target precise epitopes. For a new virus or a new construct, the suitable reagent may not always be available.
What label-free counting changes
Label-free counting significantly changes the workflow. With interferometric microscopy, the particle is detected through the interference between the scattered light and the incident beam. This approach requires no dye, no antibody, no incubation and no sheath fluid.
The Videodrop SC, for example, measures particle concentration and a number distribution from 5 to 10 µL in less than one minute. It operates without denaturation, calibration or fluidics. The image also makes it possible to visualize aggregates and debris up to 10 µm.
This approach is particularly relevant for purified and concentrated samples, rapid controls, process monitoring or steps where users need a quick indication of concentration and size.
The main limitation is the absence of biological specificity. A label-free method counts detectable particles above a threshold, but it cannot confirm that they are viral if the matrix contains other particles.
Comparing the main alternatives
| Platform | Principle | Published range | Charge | Fluorescence | Strength |
| Videodrop – Myriade Lab | ILM | Around 80-500 nm – 10^8-10^10 p/mL | No | No | Fast counting, process monitoring, 5-10 µL |
| NanoSight – Malvern Panalytical | NTA | 10-2000 nm – 10^6-10^9 p/mL | No | Yes | General sizing and counting |
| ZetaView – Particle Metrix | NTA | 10-1000 nm – 10^5-10^9 p/mL | Yes | Yes, up to 11 channels | Multiparametric work and colocalization |
| Exoid – Izon | TRPS | 40 nm-11 µm | Yes | No | Resolution, charge and particles below 80 nm |
| NanoAnalyzer – NanoFCM | Nano-flow cytometry | 40-1000 nm | No | Yes | Single-vesicle phenotyping |
| Virus Counter – Sartorius | Fluorescence-based counting | 5 x 10^5-1 x 10^9 viral particles/mL | No | Yes, required | Specific viral counting |
This table shows that the technologies do not address the same priorities. Some are adapted to fast counting, others to fluorescence, charge, resolution or subpopulation analysis.
Choosing according to concentration and particle size
Sample concentration is a decisive criterion. The Virus Counter covers a quantification range from 5 x 10^5 to 1 x 10^9 viral particles/mL. Label-free methods such as ILM operate at higher concentrations, around 10^8 to 10^10 particles/mL.
This difference is important. A diluted sample may be better suited to a labeled method, while a concentrated process stream may be suitable for label-free counting.
Particle size must also be considered. A lentivirus, around 100-130 nm, can fall within the analysis range of several optical technologies. A smaller virus such as AAV, around 25 nm, cannot be treated in the same way if the detection threshold is too high.
Comparing technologies without considering the real size of the particles can therefore lead to the wrong choice.
Knowing when to keep a labeled method
Fluorescence-based counting remains particularly useful when biological specificity is essential. This applies to crude harvests, complex matrices or situations where the main question is whether a detected particle truly corresponds to the target virus.
It may also remain necessary when samples are too diluted for a label-free method, or when the method is already established and documented in a regulated environment.
In these contexts, directly replacing the Virus Counter with a label-free optical counter may be inappropriate. It is better to consider the two approaches as complementary: fluorescence for specific data, label-free counting for rapid controls when the matrix and concentration allow it.
Building a complementary workflow
In many laboratories, the best organization is not to replace one technology with another, but to distribute use cases. Fast label-free counting can be used on purified and concentrated process material, to monitor yield, check aggregation or control stability points.
Labeled counting can be reserved for crude matrices, diluted samples, measurements requiring biological specificity or results intended to be reported in a more controlled framework.
This distribution avoids using a more expensive and longer method for every analysis, while preserving the necessary precision when viral identity must be confirmed.
Comparing the Virus Counter 3100 according to real use
The Virus Counter 3100 comparison should be built around the laboratory’s practical needs. If the priority is viral specificity, fluorescent labeling remains highly relevant. If the need focuses on fast counting, low volume, process monitoring or reduced consumables, a label-free method may become appropriate.
The choice also depends on sample concentration, virus size, purification level, fluorescence requirements and the role of the analysis in the workflow. A crude matrix, a diluted sample or a very small virus will not lead to the same decision as a purified and concentrated preparation.
A Virus Counter 3100 comparison should therefore not look for a single replacement. It should identify which technology answers which question, and under which conditions a complementary solution can improve analytical organization.
